High‐mobility Group Protein 1/ Receptor for Advanced Glycation End Products/ Nuclear Factor‐κB Signalling Pathway Contributes to the Pathogenic Process of Striatal Neuron Impairment in the Rat Model of Parkinson's Disease

Documenti analoghi

• Jingxin Zhidong Formula Alleviates Tic Disorder via Modulation of Microglial IKK/NF‐κB Signaling and Striatal Neurotransmitter Homeostasis
  di: Fei Fan, et al.
  Pubblicazione: (2026)
• Ginsenoside Rb1 Ameliorates Age‐Related Cognitive Impairment Potentially by Modulating the NF‐κB Signaling Pathway
  di: Wei‐Feng Lu, et al.
  Pubblicazione: (2026)
• Spermidine Inhibits M1 Microglia Polarization in a Mouse Model of Parkinson's Disease and BV2 Cells via NF‐κB/STAT‐1 Pathway
  di: Jun Shu, et al.
  Pubblicazione: (2025)
• Identifying Druggable Inflammatory Proteins Causally Contributing to Parkinson's Disease
  di: Ziyao Zhang, et al.
  Pubblicazione: (2025)
• Structural Volumetric Alterations in Parkinson's Disease With Mild Cognitive Impairment
  di: Jinhua Hu, et al.
  Pubblicazione: (2026)